These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 14654798)

  • 1. Opportunities in somatostatin research: biological, chemical and therapeutic aspects.
    Weckbecker G; Lewis I; Albert R; Schmid HA; Hoyer D; Bruns C
    Nat Rev Drug Discov; 2003 Dec; 2(12):999-1017. PubMed ID: 14654798
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical relevance of the expression of somatostatin receptors in digestive endocrine tumours.
    Capurso G; Panzuto F; Delle Fave G
    Dig Liver Dis; 2010 Mar; 42(3):173-4. PubMed ID: 20117969
    [No Abstract]   [Full Text] [Related]  

  • 3. The treatment algorithm of acromegaly.
    Colao A; Pivonello R; Cappabianca P; Vitale G; Lombardi G
    J Endocrinol Invest; 2003; 26(8 Suppl):39-45. PubMed ID: 15233211
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pharmacological treatment of acromegaly].
    Mercado M; Galeana M
    Gac Med Mex; 2006; 142(4):327-31. PubMed ID: 17022308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-clinical and clinical experiences with novel somatostatin ligands: advantages, disadvantages and new prospects.
    Hofland LJ; van der Hoek J; Feelders R; van der Lely AJ; de Herder W; Lamberts SW
    J Endocrinol Invest; 2005; 28(11 Suppl International):36-42. PubMed ID: 16625843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New insights on SOM230, a universal somatostatin receptor ligand.
    Boerlin V; van der Hoek J; Beglinger Ch; Poon KW; Hartmann S; Dutreix C; Kovarik JM; Bruns Ch; Weckbecker G; Lewis I; Schnieper P; Hofland LJ; Lamberts SW
    J Endocrinol Invest; 2003; 26(8 Suppl):14-6. PubMed ID: 15233205
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacological options in the treatment of acromegaly.
    Ezzat S
    Curr Opin Investig Drugs; 2005 Oct; 6(10):1023-7. PubMed ID: 16259223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of somatostatin analogs on biochemical parameters in acromegaly.
    Liuzzi A; Marzullo P
    J Endocrinol Invest; 2003; 26(8 Suppl):46-9. PubMed ID: 15233212
    [No Abstract]   [Full Text] [Related]  

  • 9. The effects of somatostatin analogs on tumor shrinkage in acromegaly.
    Pedroncelli AM; Montini M; Albizzi M; Barbò R; Pagani G
    J Endocrinol Invest; 2003; 26(8 Suppl):50-4. PubMed ID: 15233213
    [No Abstract]   [Full Text] [Related]  

  • 10. Rationale of pre-surgical medical treatment with somatostatin analogs in acromegaly.
    Cappabianca P; Cavallo LM; Esposito F; Romano I; Colao A; de Divitiis E
    J Endocrinol Invest; 2003; 26(8 Suppl):55-8. PubMed ID: 15233214
    [No Abstract]   [Full Text] [Related]  

  • 11. Conclusions: the future role of somatostatin analogs.
    Lamberts SW
    J Endocrinol Invest; 2003; 26(8 Suppl):134-5. PubMed ID: 15233230
    [No Abstract]   [Full Text] [Related]  

  • 12. Antitumor effects of somatostatin.
    Pyronnet S; Bousquet C; Najib S; Azar R; Laklai H; Susini C
    Mol Cell Endocrinol; 2008 May; 286(1-2):230-7. PubMed ID: 18359151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multimodality treatment of pituitary adenomas.
    Oyesiku NM
    Clin Neurosurg; 2005; 52():234-42. PubMed ID: 16626076
    [No Abstract]   [Full Text] [Related]  

  • 14. Bibliography. Current world literature. Endocrine tumors.
    Curr Opin Oncol; 2002 Jan; 14(1):111-20. PubMed ID: 11797656
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug insight: Primary medical therapy of acromegaly.
    Katznelson L
    Nat Clin Pract Endocrinol Metab; 2006 Feb; 2(2):109-17; quiz following 117. PubMed ID: 16932265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocrine tumours of the gastrointestinal tract. Somatostatin receptors as tools for diagnosis and therapy: molecular aspects.
    Guillermet-Guibert J; Lahlou H; Pyronnet S; Bousquet C; Susini C
    Best Pract Res Clin Gastroenterol; 2005 Aug; 19(4):535-51. PubMed ID: 16183526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current thinking on the management of the acromegalic patient.
    Katznelson L
    Curr Opin Endocrinol Diabetes Obes; 2007 Aug; 14(4):311-6. PubMed ID: 17940458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment strategy for pancreatic endocrine tumours].
    Mitry E; Rougier P
    Gastroenterol Clin Biol; 2003 Mar; 27(3 Suppl):S31-6. PubMed ID: 12704291
    [No Abstract]   [Full Text] [Related]  

  • 19. The structural basis for biological signaling, regulation, and specificity in the growth hormone-prolactin system of hormones and receptors.
    Kossiakoff AA
    Adv Protein Chem; 2004; 68():147-69. PubMed ID: 15500861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatostatin analogues in the control of neuroendocrine tumours: efficacy and mechanisms.
    Grozinsky-Glasberg S; Shimon I; Korbonits M; Grossman AB
    Endocr Relat Cancer; 2008 Sep; 15(3):701-20. PubMed ID: 18524947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.